Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= SETD1B ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: SETD1B * **<color #00a2e8>Official Name</color>**: SET domain containing 1B, histone lysine methyltransferase * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23067|23067]] * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/Q9UPS6|Q9UPS6]] * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=SETD1B&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SETD1B|Open PubMed]] * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/611055|Open OMIM]] == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: N/A * **<color #00a2e8>UniProt Summary</color>**: Histone methyltransferase that specifically methylates 'Lys-4' of histone H3, when part of the SET1 histone methyltransferase (HMT) complex, but not if the neighboring 'Lys- 9' residue is already methylated. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. The non-overlapping localization with SETD1A suggests that SETD1A and SETD1B make non-redundant contributions to the epigenetic control of chromatin structure and gene expression. Specifically tri-methylates 'Lys-4' of histone H3 in vitro. <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |N-SET| |RRM 1| |SET| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |Set1C/COMPASS complex| |histone methyltransferase activity (H3-K4 specific)| |histone H3-K4 methylation| |histone methyltransferase complex| |histone lysine methylation| |peptidyl-lysine methylation| |histone methylation| |chromosome| |protein methylation| |protein alkylation| |macromolecule methylation| |methylation| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |nuclear speck| |chromatin organization| |peptidyl-amino acid modification| |chromosome organization| |RNA binding| </modal> \\ === CRISPR Data === <button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='primary' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> ^Screen^Score^ |[[:results:exp29|Rapamycin 1μM R00 exp29]]|-2.23| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.06| |[[:results:exp280|Daidzin 10μM R06 exp280]]|-1.88| |[[:results:exp130|JQ1 0.01μM R03 exp130]]|-1.86| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|-1.82| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-1.77| |[[:results:exp470|Chloroquine 32μM R08 exp470]]|-1.72| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|1.74| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|1.89| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|2.06| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|2.38| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|2.61| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|2.83| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|3.12| </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> ^Gene^Correlation^ |[[:human genes:e:erg|ERG]]|0.435| |[[:human genes:r:runx1|RUNX1]]|0.405| </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: 2/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|1/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 450 * **<color #00a2e8>Expression level (log2 read counts)</color>**: 6.45 <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='SETD1B Expression in NALM6 Cells: 6.45'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2026/01/07 22:37by 127.0.0.1